The primary objective of the MiFrAADiF trial was the evaluation of healing rate and time of the minor amputations treated with autologous micro-fragmented adipose tissue compared with standard of care in case of irreversible DFU with resolved peripheral arterial disease.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}